GB1276218A - Calf diarrhea virus vaccine and processes - Google Patents
Calf diarrhea virus vaccine and processesInfo
- Publication number
- GB1276218A GB1276218A GB56205/70A GB5620570A GB1276218A GB 1276218 A GB1276218 A GB 1276218A GB 56205/70 A GB56205/70 A GB 56205/70A GB 5620570 A GB5620570 A GB 5620570A GB 1276218 A GB1276218 A GB 1276218A
- Authority
- GB
- United Kingdom
- Prior art keywords
- cell line
- cells
- kidney
- primary
- calf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 244000309466 calf Species 0.000 title abstract 5
- 206010012735 Diarrhoea Diseases 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 6
- 210000004027 cell Anatomy 0.000 abstract 6
- 210000003292 kidney cell Anatomy 0.000 abstract 6
- 230000001605 fetal effect Effects 0.000 abstract 4
- 102000004407 Lactalbumin Human genes 0.000 abstract 2
- 108090000942 Lactalbumin Proteins 0.000 abstract 2
- 241000282898 Sus scrofa Species 0.000 abstract 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract 2
- 241000867607 Chlorocebus sabaeus Species 0.000 abstract 1
- 241000699800 Cricetinae Species 0.000 abstract 1
- 239000012594 Earle’s Balanced Salt Solution Substances 0.000 abstract 1
- 235000019687 Lamb Nutrition 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 210000003161 choroid Anatomy 0.000 abstract 1
- 210000001728 clone cell Anatomy 0.000 abstract 1
- 230000002550 fecal effect Effects 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 210000005265 lung cell Anatomy 0.000 abstract 1
- 210000001161 mammalian embryo Anatomy 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 229960005322 streptomycin Drugs 0.000 abstract 1
- 210000001550 testis Anatomy 0.000 abstract 1
- 210000001685 thyroid gland Anatomy 0.000 abstract 1
- 210000003437 trachea Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
1276218 Calf diarrhoea vaccine C A MEBUS and M J TWIEHAUS 26 Nov 1970 [28 Nov 1969] 56205/70 Heading A5B Calf diarrhoea virus is attenuated by passaging in one of the following tissue cultures: primary fetal bovine kidney cells, primary fetal bovine lung cells, primary fetal bovine thyroid cells, primary porcine kidney cells, primary fetal bovine choroid plexes cells, primary lamb kidney cells, bovine kidney cell line, embryonic bovine trachea cell line, baby hamster kidney clone cell line, green monkey kidney cell line, pig kidney cell line, swine testicle cell line and Henle's intestine (human embryo) cell line. In typical Example I, the cells are grown on Earle's lactalbumin hydrolyzate and calf serum. Calf passage fecal filtrate is added to the culture which is incubated in a growth medium comprising Earle's balanced salt solution, lactalbumin, yeast, penicillin and streptomycin.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88095669A | 1969-11-28 | 1969-11-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1276218A true GB1276218A (en) | 1972-06-01 |
Family
ID=25377480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB56205/70A Expired GB1276218A (en) | 1969-11-28 | 1970-11-26 | Calf diarrhea virus vaccine and processes |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS55105622A (en) |
| BE (1) | BE759425A (en) |
| CA (1) | CA943063A (en) |
| DE (1) | DE2057544C3 (en) |
| DK (1) | DK132447C (en) |
| FI (1) | FI46520C (en) |
| FR (1) | FR2073429B1 (en) |
| GB (1) | GB1276218A (en) |
| NL (1) | NL7017377A (en) |
| ZA (1) | ZA707947B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0192404A2 (en) * | 1985-02-15 | 1986-08-27 | The Wistar Institute Of Anatomy And Biology | Vaccine, method for its preparation and use thereof in vaccinating humans against rotavirus infection |
| US5610049A (en) * | 1991-05-01 | 1997-03-11 | The Wistar Institute Of Anatomy And Biology | Human rotavirus HCR3A and method of growing said rotavirus |
| US5626851A (en) * | 1987-11-30 | 1997-05-06 | The Wistar Institute Of Anatomy And Biology | Rotavirus reassortant vaccine |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE419500B (en) * | 1972-10-30 | 1981-08-10 | Univ Nebraska | PROCEDURE FOR ATTENUATION OF A CORONA VIRUS-LIKE CALVDAR REVIRUS FOR PREPARATION OF CALV DIARVACCIN |
| BR0313806A (en) * | 2002-08-26 | 2005-07-05 | Pfizer Prod Inc | Vaccines for infections in the respiratory and reproductive systems in cattle |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3293129A (en) * | 1962-02-01 | 1966-12-20 | Cornell Res Foundation Inc | Immunization of cattle against virus diarrhea virus |
-
0
- BE BE759425D patent/BE759425A/en not_active IP Right Cessation
-
1970
- 1970-11-23 DE DE2057544A patent/DE2057544C3/en not_active Expired
- 1970-11-24 FR FR7042105A patent/FR2073429B1/fr not_active Expired
- 1970-11-24 CA CA098,958A patent/CA943063A/en not_active Expired
- 1970-11-24 ZA ZA707947A patent/ZA707947B/en unknown
- 1970-11-25 DK DK600770A patent/DK132447C/en not_active IP Right Cessation
- 1970-11-26 GB GB56205/70A patent/GB1276218A/en not_active Expired
- 1970-11-27 FI FI703207A patent/FI46520C/en active
- 1970-11-27 NL NL7017377A patent/NL7017377A/xx unknown
-
1973
- 1973-09-06 JP JP10073673A patent/JPS55105622A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0192404A2 (en) * | 1985-02-15 | 1986-08-27 | The Wistar Institute Of Anatomy And Biology | Vaccine, method for its preparation and use thereof in vaccinating humans against rotavirus infection |
| EP0192404A3 (en) * | 1985-02-15 | 1987-11-11 | The Wistar Institute Of Anatomy And Biology | Vaccine, method for its preparation and use thereof in vaccinating humans against rotavirus infection |
| US5626851A (en) * | 1987-11-30 | 1997-05-06 | The Wistar Institute Of Anatomy And Biology | Rotavirus reassortant vaccine |
| US5750109A (en) * | 1987-11-30 | 1998-05-12 | The Wistar Institute Of Anatomy & Biology | Rotavirus reassortant vaccine |
| US6113910A (en) * | 1987-11-30 | 2000-09-05 | The Children's Hospital Of Philadelphia | Rotavirus reassortant vaccine |
| US6290968B1 (en) | 1987-11-30 | 2001-09-18 | Children's Hospital Of Philadelphia | Rotavirus reassortant vaccine |
| US5610049A (en) * | 1991-05-01 | 1997-03-11 | The Wistar Institute Of Anatomy And Biology | Human rotavirus HCR3A and method of growing said rotavirus |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2057544B2 (en) | 1978-06-29 |
| FI46520B (en) | 1973-01-02 |
| ZA707947B (en) | 1971-10-27 |
| NL7017377A (en) | 1971-06-02 |
| DE2057544C3 (en) | 1979-02-22 |
| DK132447B (en) | 1975-12-08 |
| JPS55105622A (en) | 1980-08-13 |
| DE2057544A1 (en) | 1971-06-09 |
| FR2073429B1 (en) | 1974-03-22 |
| CA943063A (en) | 1974-03-05 |
| BE759425A (en) | 1971-05-25 |
| FI46520C (en) | 1973-04-10 |
| DK132447C (en) | 1976-05-10 |
| FR2073429A1 (en) | 1971-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kapsenberg | Possible antigenic relationship between varicella/zoster virus and herpes simplex virus | |
| GB1531762A (en) | Cancer antigen cancer therapy and cancer diagnosis | |
| DE3164143D1 (en) | Production of viral antigens | |
| US3887430A (en) | Culture medium for tissue culture techniques | |
| Hahn et al. | Lymphoproliferative diseases of fowl: JM-V leukemic lymphoblasts in cell culture: brief communication | |
| GB1276218A (en) | Calf diarrhea virus vaccine and processes | |
| GB1535063A (en) | Process for preparing a curative agent for myelogenic leukemia | |
| US4055466A (en) | Culture medium for tissue culture techniques | |
| IE40221L (en) | Influenza vaccines | |
| GB958344A (en) | Attenuated live rabies vaccine and method of preparing the same | |
| Geiman | New Media for the Growth of Bartonella bacilliformis. | |
| York et al. | Isolation and identification of infectious bovine rhinotracheitis virus in tissue culture | |
| GB1358321A (en) | Method od tissue cell culture | |
| PT72015B (en) | Process for preparing "invitro" cultures of hepatitis b virus | |
| ES385968A1 (en) | Highly attenuated newcastle disease virus vaccine and production thereof | |
| GB878704A (en) | Propagation of attenuated infectious canine hepatitis virus in trypsinized tissue cultures of pig kidney and the preparation of a vaccine therefrom | |
| GB839876A (en) | A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus | |
| US3096247A (en) | Infectious rhinotracheitis virus attenuated in lamb cell tissue cultures | |
| Stout | Saprophilus muscorum Kahl, a tetrahymenal ciliate | |
| Kagen et al. | Myoglobin synthesis in embryonic cells: Production by both “red” and “white” muscle in cell culture estimated by radioimmunoassay | |
| Ogawa et al. | Incubation period for tumor induction by adenovirus type 12 | |
| GB1465345A (en) | Equine infectious anemia vaccine | |
| GB904301A (en) | A composite vaccine for the immunization of dogs and foxes against distemper and hepatitis contagiosa canis | |
| GB1414076A (en) | Process for monitoring cell and vaccine production | |
| GB1105179A (en) | Improvements in or relating to propagating human hepatitis virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLE | Entries relating assignments, transmissions, licences in the register of patents | ||
| PE20 | Patent expired after termination of 20 years |